~20 spots leftby May 2025

Exercise Training for Brachial Plexus Injury

Recruiting in Palo Alto (17 mi)
Age: 18 - 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: University of Alberta
No Placebo Group
Prior Safety Data
Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?

Although peripheral nerve is capable of regrowth following injury, at only 1 mm/day, the slow rate represents a major barrier. Apart from rapid deterioration of the environment supportive of growth, denervated muscles become atrophic and bones osteoporotic. To successfully restore function, in addition to speeding up the nerve regeneration rate, treatments that can also restore muscle and bone mass are essential. Recently, in animal studies, the investigators showed that in addition to accelerating the speed of nerve regeneration, exercise training can also be used to restore muscle bulk and bone density. While promising, given the inter-species differences, the clinical utilities of this treatment need to be directly tested in humans. This will be done using a randomized controlled study design on patients with brachial plexus injury.

Research Team

Eligibility Criteria

This trial is for adults aged 18-60 with a specific nerve injury in the arm called brachial plexus injury, confirmed by special nerve tests. Participants must be able to give consent. Those with other conditions affecting arm and hand function cannot join.

Inclusion Criteria

Able to consent for participation
I am between 18 and 60 years old.
I have a confirmed nerve injury in my shoulder area.

Exclusion Criteria

I have a condition affecting my elbow or hand function.

Treatment Details

Interventions

  • Exercise Training (Behavioural Intervention)
Trial OverviewThe study is testing if exercise training can help people recover from brachial plexus injuries by speeding up nerve healing and improving muscle and bone health. It's a randomized controlled trial, meaning participants are randomly assigned to either the exercise group or a control group.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Exercise groupExperimental Treatment1 Intervention
Each participant in the exercise group will undergo hand grip exercise for 30 minutes a day, 5 days a week for a total of 12 weeks. To activate the ulnar nerve innervated muscles, the exercise will be done using an electronic hand grip device with adjustable resistance individualized to the strength of each participant.
Group II: Control groupExperimental Treatment1 Intervention
Participants will carry out a stretch exercise routine that is not known to have any effect on nerve regeneration.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alberta

Lead Sponsor

Trials
957
Recruited
437,000+
Bill Flanagan profile image

Bill Flanagan

University of Alberta

Chief Executive Officer since 2020

LLB from University of Toronto, LLM from Columbia University

Dr. Verna Yiu profile image

Dr. Verna Yiu

University of Alberta

Chief Medical Officer since 2012

MD from University of Alberta, Fellowship in Pediatric Nephrology at Harvard University

Royal Alexandra Hospital

Collaborator

Trials
20
Recruited
9,300+

Glenrose Foundation

Collaborator

Trials
10
Recruited
2,500+